[{"Assets_0_Q1_USD":33083000000.0,"CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q1_USD":0.4,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":0.91,"EarningsPerShareDiluted_1_Q1_USD":0.91,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1175000000.0,"NetIncomeLossConverted_1_Q1_USD":1486000000.0,"OfficialName":"Bristol-Myers Squibb Company Common Stock","RevenuesConverted_1_Q1_USD":5193000000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":12906000000.0,"StockholdersEquity_0_Q1_USD":12793000000.0,"Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1640000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1633000000.0,"filed":"20180426","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2018.0","name":"BRISTOL MYERS SQUIBB CO","period":"20180331","qtrs":"0","uom":"USD"}]